Zobrazeno 1 - 10
of 17
pro vyhledávání: '"John I. Wurzelmann"'
Autor:
Mbbs Linda Kalilani, Mph John I. Wurzelmann, PharmD Stephen W. Janning, Rachel E. Williams, PhD, Ms, BS Timothy J. Sampson
Publikováno v:
Journal of Opioid Management. 4:145-152
Objective: To describe opioid pharmacy claims patterns in the United States among an insured population.Design: Information was obtained from the US insurance claims database, IMS Lifelink™, between 1997 and 2002. Descriptive statistics of opioid c
Autor:
Peter Adamson, Megan M. McLaughlin, Ronald P. Danis, Mindy Magee, John I. Wurzelmann, Li Ye, Giovanni Staurenghi
Publikováno v:
Ophthalmology. 122:990-996
Purpose To investigate the potential of lipoprotein-associated phospholipase A 2 inhibition as a novel mechanism to reduce edema and improve vision in center-involved diabetic macular edema (DME). Design Prospective, multicenter, randomized, double-m
Autor:
Michael Fries, Deborah S. Kelly, Ronald P. Danis, John I. Wurzelmann, Trupti Trivedi, Chun-Fang Xu, Pravin U. Dugel, Amy J. Pierce, Karl G. Csaky, Mohammad Hossain
Publikováno v:
Ophthalmology. 122:579-588
Purpose To evaluate pazopanib eye drops in subjects with active subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD). Design Multicountry, randomized, parallel-group, double-masked, active and placebo-contr
Autor:
Trupti Trivedi, Rishi Singh, Linda S. Henderson, Li Ye, John I. Wurzelmann, Mohammad Hossain, Deborah S. Kelly
Publikováno v:
Retina. 34:1787-1795
To evaluate pazopanib 10 mg/mL eye drops (pazopanib) in healthy subjects and in subjects with previously untreated subfoveal choroidal neovascularization secondary to age-related macular degeneration.Study 1 (single center, randomized, placebo-contro
Publikováno v:
Pharmacoepidemiology and Drug Safety. 20:754-762
BACKGROUND We estimated the incidence of myocardial infarction (MI) and coronary revascularization (CR) among users of chronic opioid therapy (COT) and compared risks across categories of morphine-equivalent doses of COT and comparator cohorts. METHO
Autor:
Amy Pierce, John Langan, Kai Hermanns, John I. Wurzelmann, Christi S. Kleoudis, Daniel Lorch, Jerry Snidow, E. Mortensen, Ben Lasko, Jan-Peter Jansen
Publikováno v:
The Journal of Pain. 12:185-193
Gastrointestinal (GI) side effects are common with opioid medication, and constipation affects ∼40% of patients. Such symptoms considerably impair patients' quality of life. Alvimopan is an orally administered, systemically available, peripherally
Autor:
David M. Kleinman, Michael Fries, Diane E Balderson, Megan M. McLaughlin, Sheila B Young, John I. Wurzelmann, Gengqian Cai, Trupti Trivedi
Publikováno v:
BMC Ophthalmology
Background This objective of the review and analysis is to demonstrate that acyclovir (ACV) 3% ophthalmic ointment is superior to idoxuridine (IDU) in treating herpetic keratitis (HK) presenting as dendritic and geographic ulcer sub-types. Methods Da
Publikováno v:
Journal of Clinical Gastroenterology. 20:317-320
Most colorectal cancers are thought to develop from benign adenomas. Because adenomas are found in a large proportion of asymptomatic individuals, most adenomas must remain benign. Current guidelines suggest that colonoscopy is not necessary when hyp
Publikováno v:
Digestive Diseases and Sciences. 39:555-560
Adults with inflammatory bowel disease from North Carolina were questioned during 1986 and 1987 to assess risk due to a variety of childhood infections and treatments with antibiotics. Responses were compared with those of neighbor controls. Persons
Publikováno v:
Epidemiology. 3:374-378
We used rosters of the Crohn's and Colitis Foundation of America to identify potential cases and peer-nominated controls to explore the reported association between oral contraceptives and inflammatory bowel disease. Overall, women who used oral cont